PainChek® is now becoming the new global standard in pain assessment within Residential Aged Care.
The first PainChek® clinical pain assessment in aged care was at Barossa Village in South Australia. PainChek® has now established itself as the new standard in pain assessment and has expanded across the whole of Australia and around the globe.
PainChek® is a clinically validated medical device and meets regulatory standards for use in Australia, New Zealand, the United States, Canada, Singapore, Malaysia, the United Kingdom, and the European Union.
PainChek® is now licensed in over 1,900+ aged care facilities covering four regions of the world and 15.9 million cumulative pain assessments have been conducted to date.
The PainChek® Universal solution enables better pain management by:
-
-
- Giving a voice to those who cannot reliably verbalise their pain, through a unique AI driven assessment tool
-
- Document the pain for those who can self-report, and
- Providing the right pain assessment solution for those whose ability to communicate fluctuates
-
All directly available at the point of care. Click here for more information
PainChek® is a fully digital healthcare solution and can be operated from up to 3m away from the person being assessed. This aligns with social distancing requirements, minimising infection risks during both the current COVID-19 crisis, and any future viral outbreaks which may impact the vulnerable.
Finally, PainChek® Universal helps to keep all your processes aligned as it integrates directly into Care Management Systems. Pain data is safely stored in one place from which powerful real-time reporting via PainChek® Analytics supports your critical clinical decision-making.
For more information on case studies, click here
15,900,000
pain assessments conducted worldwide
